Cargando…
Development of NMR and thermal shift assays for the evaluation of Mycobacterium tuberculosis isocitrate lyase inhibitors
The enzymes isocitrate lyase (ICL) isoforms 1 and 2 are essential for Mycobacterium tuberculosis survival within macrophages during latent tuberculosis (TB). As such, ICLs are attractive therapeutic targets for the treatment of tuberculosis. However, there are few biophysical assays that are availab...
Autores principales: | Bhusal, Ram Prasad, Patel, Krunal, Kwai, Brooke X. C., Swartjes, Anne, Bashiri, Ghader, Reynisson, Jóhannes, Sperry, Jonathan, Leung, Ivanhoe K. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072051/ https://www.ncbi.nlm.nih.gov/pubmed/30108733 http://dx.doi.org/10.1039/c7md00456g |
Ejemplares similares
-
Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2
por: Bhusal, Ram Prasad, et al.
Publicado: (2019) -
Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase
por: Ibeji, Collins U., et al.
Publicado: (2020) -
Modulation of Central Carbon Metabolism by Acetylation of Isocitrate Lyase in Mycobacterium tuberculosis
por: Bi, Jing, et al.
Publicado: (2017) -
Discovery of a Novel Inhibitor Structure of Mycobacterium tuberculosis Isocitrate Lyase
por: Duan, Changyuan, et al.
Publicado: (2022) -
Potential Inhibitors for Isocitrate Lyase of Mycobacterium tuberculosis and Non-M. tuberculosis: A Summary
por: Lee, Yie-Vern, et al.
Publicado: (2015)